Signal #144106 · SEC 8-K

$AMLX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $AMLX filing catalyst

Why did $AMLX trigger an AI stock catalyst alert?

$AMLX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Amylyx Q3 2026: Net Loss Widens to $45.5M, NDA Track Intact. Key points: - Q3 2026 net loss expanded to $45.5M ($0.38/share) vs $34.4M ($0.37/share) YoY. - Total operating expenses rose to $49.6M, driven by higher R&D ($28.4M) and SG&A ($21.3M). - Balance sheet bolstered via offering; NDA submission for avexitide remains on track for end of 2026.

How did $AMLX stock react after the SEC filing?

After the SEC 8-K for $AMLX, observed market reaction: T0 price $29.40. Past moves do not guarantee future results.

Where can I get real-time $AMLX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $AMLX via Telegram and the VIP Web Terminal from €10/month.

$AMLX

$AMLX – Amylyx Q3 2026: Net Loss Widens to $45.5M, NDA Track Intact

Amylyx Pharmaceuticals, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $AMLX

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 2026 net loss expanded to $45.5M ($0.38/share) vs $34.4M ($0.37/share) YoY.
Total operating expenses rose to $49.6M, driven by higher R&D ($28.4M) and SG&A ($21.3M).
Balance sheet bolstered via offering; NDA submission for avexitide remains on track for end of 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →